Hepatitis B Safety Screening - ICD-10-CM Quality Payment Program Measure

Quality Measure Description High Priority Submission Methods
Hepatitis B Safety ScreeningIf a patient is newly initiating biologic OR new synthetic DMARD therapy (e.g. methotrexate, leflunomide, etc.), then the medical record should indicate appropriate screening for hepatitis B in the preceding 12 month period.YESRegistry

Linked ICD-10 Codes

The following ICD-10-CM codes are linked to the quality measure hepatitis b safety screening when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).

ICD CodeDescriptionCategory

View All Quality Payment Program Measures